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ure that identifies central regions within networks. Carrying an apolipoprotein 
(APOE)-	ε4	allele	is	a	genetic	risk	for	AD,	associated	with	increased	amyloid	deposi-











Conclusion:	Our	findings	suggest	that	the	APOE-	ε4 genotype affects brain connec-
tivity	in	regions	previously	found	to	be	abnormal	in	AD	as	a	sign	of	very	early	disease-	
related pathology. These differences were too subtle in healthy elderly to use EC for 
single-	subject	prediction	of	APOE	genotype.
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1  | INTRODUC TION
1.1 | The role of amyloid- β in Alzheimer’s disease
The accumulation of amyloid- β	 (Aβ)	 plaques	 in	 the	brain	 is	 one	of	
the	 first	events	 in	 the	pathological	 cascade	 leading	 to	Alzheimer’s	
disease	(AD)	(Bateman	et	al.,	2012;	Hardy	&	Selkoe,	2002;	Sperling	
et	al.,	 2010).	 Aβ	 disrupts	 synaptic	 functioning,	 resulting	 in	 aber-
rant	brain	connectivity	at	 the	synaptic	 level	 (Selkoe,	2002;	Spires-	
Jones	&	Hyman,	2014),	as	well	as	on	the	whole-	brain	connectivity	
level	(Delbeuck,	der	Linden,	&	Collette,	2003;	Hedden	et	al.,	2009).	
Although	 the	precise	 sequence	of	events	caused	by	Aβ	 plaques	 is	
still	 being	 investigated	 (Altmann,	 Ng,	 Landau,	 Jagust,	 &	 Greicius,	
2015)	 and	 interactions	with	 other	 agents	 recognized	 (Jones	 et	al.,	
2017),	 the	 key	 role	 of	 Aβ	 in	 AD	 pathology	 is	 beyond	 doubt	 (Jack	
et	al.,	2016).
1.2 | The APOE- ε4 allele and Aβ pathology
Carrying	 the	APOE-	ε4	allele	 is	 the	main	genetic	 risk	 factor	 for	Aβ 
deposition	(Ba	et	al.,	2016;	Verghese,	Castellano,	&	Holtzman,	2011;	
Yu,	Tan,	&	Hardy,	2014).	Recent	findings	show	that	the	ε4 isoform 
of	the	ApoE	protein	 is	 less	efficient	 in	clearing	Aβ compared to ε2 
and ε3,	 leading	 to	accelerated	aggregation	of	plaques.	Early	 imag-
ing	studies	show	hypometabolism	in	AD-	specific	regions	in	APOE-	ε4 
carriers	(Reiman	et	al.,	1996).	Carriers	have	also	shown	detrimental	
effects	on	cognition	 in	old	age	 (Deary	et	al.,	2002).	Recent	 results	
show	 the	 correlation	 of	 APOE-	ε4	 carriership	 with	 Aβ	 deposition,	
cognition,	 and	 brain	 atrophy	 (Bonham	et	al.,	 2016;	 ten	Kate	 et	al.,	
2016;	Lim	&	Mormino,	2017).	APOE-	ε4	carriers	show	abnormal	Aβ 
plaque	 deposition	 at	 relatively	 younger	 ages	 (Jansen	 et	al.,	 2015;	
Strittmatter,	Weisgraber,	et	al.	1993).
1.3 | Brain connectivity and resting- state 
functional MRI
Brain	 connectivity	 is	disrupted	 in	AD	 (Binnewijzend	et	al.,	 2012;	
Tijms	 et	al.,	 2013,	 2014),	 indicating	 that	 AD	 is	 a	 disconnectivity	
disorder.	 Resting-	state	 functional	 MRI	 (RS-	fMRI)	 detects	 func-
tional	connections	in	the	brain	as	synchronized	activity	between	
brain	regions	in	the	absence	of	a	task	(Binnewijzend	et	al.,	2012).	
Brain	 regions	 linked	 to	 AD	 pathology	 in	 studies	 using	MEG	 and	
structural	MRI	(de	Haan,	Mott,	et	al.,	2012;	de	Haan,	van	der	Flier,	
et	al.,	2012;	Tijms	et	al.,	2013)	show	high	connectivity	in	RS-	fMRI;	
they are hub regions.	The	high	vulnerability	of	hubs	for	AD	is	also	
found	 in	 RS-	fMRI	 studies	 (Buckner	 et	al.,	 2009;	Qi	 et	al.,	 2010).	
The	 default	 mode	 network	 (DMN)	 and	 other	 resting-	state	 net-
works,	that	is,	regions	with	synchronized	fMRI	activity,	have	been	
studied	as	markers	for	AD	progression	(Binnewijzend	et	al.,	2012;	
Filippini	 et	al.,	 2009;	 Sheline	 et	al.,	 2010).	 Functional	 brain	 con-
nectivity changes in healthy adults are related to amyloid deposi-
tions	 (Hedden	et	al.,	 2009;	 Sperling	 et	al.,	 2009),	 and	 carriers	of	
the	APOE-	ε4	 allele	 show	 increased	 co-	activation	with	 the	DMN	
in	 young	 adults	 (Bookheimer	 et	al.,	 2000;	 Filippini	 et	al.,	 2009),	
indicating	 that	 functional	 connectivity	 is	 sensitive	 to	AD-	related	
alterations	of	 the	brain.	This	 study	extends	 these	previous	 find-
ings,	using	a	large	sample	from	a	population	imaging	study,	com-
bined	with	 comprehensive	AD-	related	 cognitive	 assessment	 and	
genotyping.
1.4 | Functional brain network hubs: eigenvector 
centrality and its relevance to AD
In	graph	theory,	 the	notion	of	centrality	 (Bavelas,	1948)	expresses	








where patients have decreased EC compared to healthy controls in 





ity to changes before the stage of cognitive decline and irreversible 
brain	atrophy.	This	stage	of	milder	cognitive	problems,	accompanied	
by	localized	changes	in	brain	metabolism	and	functioning	(Jack	et	al.,	
2010,	 2013),	 provides	 an	opportunity	 for	 treatment	 (Cummings	&	
Zhong,	 2014;	 Hampel	 et	al.,	 2010).	 Biomarkers	 related	 to	 disease	
progression	in	these	early	stages	are	essential	for	proper	quantita-
tive	evaluation.	If	EC	detects	AD-	related	network	alterations	in	the	
presymptomatic stage of the disease or in people with a well- defined 
risk	for	AD,	this	will	further	increase	opportunities	for	treatment	de-
velopment	(Cummings	&	Zhong,	2014;	Jack	et	al.,	2013).
The aim of this study was to determine whether eigenvector 
centrality	mapping	 (ECM)	 can	 detect	 early	 changes	 related	 to	 ge-
netic	risk	of	AD	in	cognitively	normal	adults.	In	a	specific	manner,	we	
expected	that	healthy	subjects	at	 increased	risk	for	AD	due	to	the	




2  | METHODS AND MATERIAL S
2.1 | Participants
Participants were recruited via the media between 2011 and 
2013	as	part	of	 the	networks@risk	project	at	CITA-	Alzheimer,	San	
Sebastian,	Spain,	 for	 the	Gipuzkoa	Alzheimer	Project	 (GAP),	a	 lon-
gitudinal	population	study	of	AD	risk	in	the	Basque	region	of	Spain	
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(Martinez-	Lage	et	al.,	2013),	 approved	by	 the	Gipuzkoa	clinical	 re-
search ethics committee. The sampled population was a group of 
healthy	 community-	dwelling	 participants	 aged	 39–80	years	 old.	
Healthy	subjects	without	memory	complaints,	with	a	clinical	demen-
tia	 rating	 (CDR)	<	1	 and	 a	Mini-Mental	 State	Examination	 (MMSE)	
test	score	of	at	least	28,	were	included.	Exclusion	criteria	were	any	
psychiatric,	 neurological,	 or	 systemic	 symptoms	 that	 could	 cause	
cognitive	deficits,	resulting	in	a	representative	sample	of	the	healthy	
citizens	in	this	age	group.
Subjects	 gave	 written	 informed	 consent;	 the	 study	 was	 ap-
proved	 by	 the	Gipuzkoa	medical	 and	 research	 ethical	 committee.	
Visits	included	MR	scanning,	medical	tests	and	interviews,	as	well	as	
extensive	 neuropsychological	 testing.	 The	 Framingham	 cardiovas-
cular	risk	index,	which	is	strongly	correlated	with	the	probability	of	
dementia	and	AD	(D’Agostino	et	al.,	2008),	was	computed	for	each	
participant to be used as a covariate for removing cardiovascular 
risk confounds.
2.2 | APOE genotyping
APOE	 genotype	was	 obtained	 using	 one-	stage	 PCR	 as	 previously	
described	 (Alcolea	et	al.,	 2014;	Martinez-	Lage	et	al.,	 2013)	 and	di-
chotomized	as	no	APOE-ε4	allele	(APOE4−)	or	at	least	one	APOE-ε4 
allele	 (APOE4+).	Risk	for	AD	was	defined	by	APOE	genotype,	with	
APOE4+	 being	 the	 high-	risk	 group	 (Strittmatter,	 Saunders,	 et	al.	
1993)	as	in	previous	studies	of	these	data	(ten	Kate	et	al.,	2016;	Tijms	
et	al.,	2016).	Further	subdivisions	by	genotype	were	not	possible	be-





rapid	gradient	echo	 (MPRAGE)	sequence,	1.25-	mm	 isotropic	 reso-





slice	 thickness,	 and	 3.0	×	3.0	mm	pixels.	 To	 reduce	 scanning	 time,	
the EPI slice stack had partial brain coverage and was oriented to 
include	the	regions	of	the	DMN	to	be	detected	in	a	separate	analy-
sis.	Normalized	 gray	matter	 volume	 (NGMV)	 as	 a	 fraction	of	 total	
brain	volume	was	 computed	using	 the	 segmented	MPRAGE	scans	





nonbrain	 tissue	 using	 the	 VBM8	 toolbox	 (see	 http://dbm.neuro.
uni-jena.de/vbm).	The	rest	of	the	processing	was	performed	using	
FSL	 (Smith	 et	al.,	 2004)	 as	 follows.	 The	 structural	 images	 were	
mapped	into	the	standard	MNI	space	(Mazziotta	et	al.,	2001)	using	







&	 Petersen,	 2012).	 The	 realigned	 data	 were	 spatially	 smoothed	
with	a	3D	Gaussian	filter	(full	width	at	half	the	maximum	3.3	mm	
isotropic),	and	an	edge-	preserving	nonlinear	filter	(Smith	&	Brady,	
1997).	Time	 series	were	high-	pass	 filtered	at	 a	 cutoff	 frequency	
of	182	s	(100	TR).	The	RS-	fMRI	data	of	each	subject	were	mapped	
to	 the	 native-	space	 structural	 MR	 image	 using	 boundary-	based	
registration	 (Greve	 &	 Fischl,	 2009),	 after	 which	 the	 standard	




sive	motion,	 e.g.,	 too	 high	 FD	 values	 as	 evaluated	 and	 reported	
by	 the	 preprocessing	 software	 (mean	 displacement	 >	 0.5	mm),	
missing	 data	 and/or	 failed	 registration	 to	 the	 anatomical	 scans),	
leaving	261	preprocessed	fMRI	data	sets.	Two	separate	versions	
of the preprocessed data were used: one that was preprocessed 
as	above,	and	one	where	the	effects	of	motion	were	computed	in	










Frobenius	 theorem	 guarantees	 positive	 values	 in	 the	 dominant	
eigenvector	 (Wink	 et	al.,	 2012).	 The	 fastECM algorithm allows 
the computation of this eigenvector without the need to com-
pute or store R	explicitly,	thus	increasing	efficiency	and	enabling	
fast	 computations	 at	 high	 resolutions	 (see	 https://github.com/
amwink/bias/tree/master/matlab/fastECM).	 Centrality	 was	 only	
computed inside the intersection of all single- subject masks based 
on	the	standard-	space	fMRI	data	to	ensure	the	network	topology	
under	 investigation	 did	 not	 differ	 between	 subjects,	 simplifying	
between-	group	 comparisons	 (van	 Wijk,	 Stam,	 &	 Daffertshofer,	
2010).	Single-	subject	masks	were	made	by	computing	the	tempo-
ral	minimum	for	each	4D	volume.	Two	separate	ECM	were	com-
puted	 for	 each	 subject:	 one	 with,	 and	 one	 without	 the	 motion	
parameters	regressed	out	as	explained	before.
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2.6 | Statistical analysis
2.6.1 | Eigenvector centrality differences between 
risk groups
Maps	 of	 voxelwise	 group	 mean	 EC	 values	 were	 computed	 for	
APOE4+	 and	 4−	 groups	 separately.	 Significant	 differences	 be-
tween	 the	 APOE4+	 and	 APOE4−	 groups	 were	 computed	 in	
a	 group-	level	 general	 linear	 model	 (GLM)	 whose	 design	 in-
cluded	 gender,	 age,	 NGMV,	 and	 Framingham	 index	 as	 covari-
ates.	 Significance	 was	 computed	 based	 on	 permutation	 testing	
of	 group	 labels,	 using	 cluster	mass	 as	 a	 test	 statistic	 (Bullmore	
et	al.,	 1999).	 A	 cluster-	forming	 threshold	was	 automatically	 de-
termined	 to	maximize	 the	number	 of	 suprathreshold	 clusters	 in	
the null distribution. Cluster mass statistics were computed in 
the observed and null data; the cluster mass threshold for signifi-
cance	was	set	to	yield	at	most	one	expected	false-	positive	cluster	
per image. The group analysis was performed twice: once for the 
original	ECM,	and	once	for	the	ECM	with	the	motion	parameters	






2.6.2 | Relation of eigenvector centrality and 
markers of AD risk
Mean	 centralities	 were	 computed	 for	 every	 subject	 inside	 the	
cluster mask. Correlations of EC values with biological and 
neuropsychological	 markers	 of	 AD	 risk	 were	 computed	 with	 R	
(www.r-project.org,	 version	 3.3.3).	 Linear	 fits	 were	 plotted	 of	
cluster	mean	 ECM	 against	 age	 and	 scores	 on	 the	 psychological	
tests	and	CSF	biomarker	levels,	grouped	by	genetic	risk	(APOE4−	
vs.	 APOE4+).	 Separate	 one-	way	 analyses	 of	 variance	 (ANOVA)	
with group as the factor determined the effect of the markers 
and group on the mean EC. Differences in mean EC were assessed 
by	ANOVA	of	group	mean	+individual	means,	for	both	groupings	
separately.
2.6.3 | Use of cluster mean ECM as a predictor for 
AD risk
To test the usability of single- subject cluster mean EC as a predic-
tor	 of	 genetic	 AD	 risk,	 a	 logistic	 regression	 was	 used	 to	 predict	
the	APOE	 risk	of	 each	 subject,	 using	 cluster	mean	EC	as	 the	pre-






confidence intervals were computed using bootstrap resampling. 




Of	 the	 total	 sample,	 76	 (29%)	 individuals	 were	 APOE-	ε4 carrier 
subjects	 (Table	1).	 MMSE	 scores	 were	 not	 statistically	 different	









Whole sample APOE4− group APOE4+ group p
Number	of	subjects 261 185	(71%) 76	(29%)
Male/female 110/151 78/107 32/44 0.993
Age	mean/SD 56.6/6.7 57.0/6.8 55.6/6.6 0.065
MMSE	mean/SD 29.1/0.8 29.0/0.7 29.1/0.8 0.219
15OT	score	
mean/SD
13.1/1.78 13.0/1.86 13.5/1.51 0.025*
Framingham	CV	
risk
6.46/6.17 6.41/6.16 6.61/6.27 0.660








groups in the sample
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and	 red	 shades	 show	 (a)	 the	mask	 in	which	 the	 EC	was	 computed	
(green	+	red)	and	 (b)	 the	 regions	with	higher	EC	 in	 the	APOE4+	risk	
group	(red)	and	lower	(in	green).	Most	of	the	cortical	regions	show	a	
lower	mean	centrality	for	the	APOE4+	group.	(Xia,	Wang,	&	He,	2013).
3.3 | Correlations of EC with nonimaging markers
For	each	subject,	we	extracted	the	mean	EC	inside	the	occipital	clus-





subgroup,	but	not	in	the	APOE4+	subgroup	(p = 0.012 vs. p	=	0.058)	
and there were no significant interactions. Cluster mean EC was sig-
nificantly	 negatively	 correlated	with	CSF	 amyloid	 levels	 (p	=	0.018,	




There were three statistically significant correlations of cluster 
mean	EC	with	cognitive	markers.	First,	the	15OT	(p = 0.001 for the 
whole group; p	<	0.001	and	p	=	0.481	for	the	APOE4−	and	APOE4+	
subgroups,	 respectively;	 see	Figure	2d)	and	also	 the	 time	 required	
for	the	trail-	making	test,	parts	A	(p	=	0.030)	and	B	(p	=	0.006).	For	
both	parts	of	the	test,	the	correlations	are	stronger	in	the	APOE4−	
subgroup	 than	 APOE4+	 (part	 A:	 p = 0.032 vs. p	=	0.665,	 part	 B:	
p	=	0.035	vs.	p	=	0.102;	see	Figure	2e,f).
3.4 | Use of cluster mean ECM as a predictor for AD risk
The cross- validation of the logistic regression produced an accuracy 
of	68.9%,	and	the	ROC	corresponding	to	the	parameter	λ with the 




The	 main	 result	 of	 this	 study	 is	 that	 APOE-	ε4 carriers show de-
creased EC in comparison with noncarriers in visual cortical regions; 
which	have	previously	been	demonstrated	to	be	affected	in	MCI	and	
AD	(Rombouts	et	al.,	2009;	Sanz-	Arigita	et	al.,	2010).	Furthermore,	
lower EC values were associated with older age and worse visual 
task performance in noncarriers.
4.1 | APOE- ε4- related differences in functional 
brain eigenvector centrality
Our findings show that functional whole- brain network centrality 
changes may already be present in cognitively normal older adults 
who	have	an	increased	risk	of	developing	AD.	Previous	studies	that	
have	measured	 functional	brain	changes	with	 fMRI	between	AD	
patients,	MCI	 patients	 and	 healthy	 controls	 (Binnewijzend	 et	al.,	
2012;	Drzezga	et	al.,	2011;	Ossenkoppele	et	al.,	2013),	have	dem-
onstrated	functional	changes	 in	early	stages	of	AD.	Our	findings	
are	 in	 line	with	 these	previous	observations,	 showing	 that	 these	
functional	changes	are	also	present	in	carriers	of	the	APOE-	ε4 al-
lele,	a	risk	factor	for	AD.
The regions of changed centrality partially coincide with previ-
ous work that reported brain regions with default mode network 
(DMN)-	related	 changes	 in	APOE-	ε4	 carriers	 (Filippini	 et	al.,	 2009),	
most markedly the precuneus. Those did not include the visual cor-
tex	 as	 the	 statistical	 analyses	 were	 limited	 to	 changes	 inside	 the	
DMN.	Analyses	of	 connectivity	with	 the	 rest	of	 the	brain	 (Agosta	
et	al.,	2012)	show	differential	connectivity	with	the	DMN	with	the	
same	visual	regions	we	report,	between	AD	and	controls	as	well	as	





Filippini,	 Ebmeier,	 &	 Mackay,	 2011;	 Mevel,	 Chételat,	 Eustache,	 &	
Desgranges,	2011).	Overall,	 the	most	 frequently	reported	changes	
are	 weakened	 DMN	 connectivity	 in	 middle-	aged	 and	 older	 sub-
jects	 (Goveas	 et	al.,	 2013;	 Machulda	 et	al.,	 2011;	 Reiman	 et	al.,	
1996;	 Sheline	et	al.,	 2010;	Wang	et	al.,	 2012)	 and,	 less	 frequently,	
increased	DMN	connectivity	 in	young	adults	 (Filippini	et	al.,	2009;	
Fleisher	 et	al.,	 2009).	Our	 results	 demonstrate	 early	 visual	 effects	
in a population study with realistic proportions of carriers and non-
carriers,	which	shows	the	applicability	of	 functional	measures	 in	a	
community setting.
Recent	 studies	 that	 focus	 less	 on	 the	 DMN	 alone	 report	 a	
shift of functionally central and highly connected regions from 
posterior	 to	 frontal	 regions	 in	 AD	 patients	 (Agosta	 et	al.,	 2012;	
Binnewijzend	et	al.,	2014;	Sanz-	Arigita	et	al.,	2010;	Sheline	et	al.,	
2010).	 The	 decreased	 centralities	 of	 posterior	 regions	 in	 the	
APOE4+	risk	group	found	in	this	study	are	 in	 line	with	this	shift,	
although we did not find locally increased centralities in frontal 
areas in healthy subjects.
Functional	brain	network	changes	related	to	(risk	of)	AD	have	
mainly	 been	 studied	 using	 techniques	 that	 detect	 the	 DMN.	
Tested	as	a	whole,	patients	exhibit	lower	DMN	connectivity	than	
controls,	 see	 (Wang	 et	al.,	 2015;	 Lee	 et	al.,	 2016)	 and	 their	 ref-
erences.	 The	 “canonical”	 pattern	 of	 the	 DMN	 is	 the	 precuneus,	
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F IGURE  1  (a)	Group	mean	ECM	for	
the	APOE4−	group	(top)	and	the	APOE4+	
group	(bottom).	Centralities	could	only	
be computed in brain regions that were 
scanned	in	every	subject	(colored	part).	
Blue	indicates	relatively	low	centralities,	
and yellow indicates high centralities. 
The occipital region indicated by the 
green	arrow	has	visibly	higher	voxelwise	




anatomical background is shown in gray 
scales.	Areas	where	the	mean	centrality	
is	highest	in	the	APOE4+	group	are	in	red,	
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superior	 lateral	 parietal	 lobes,	 and	 the	ACC.	When	 analyses	 are	
limited	to	the	DMN	regions,	this	 is	where	the	changes	are	found	
(Binnewijzend	et	al.,	2012;	Filippini	et	al.,	2009).	Analyses	of	AD-	
related functional brain network differences associated with the 
DMN	but	 not	 part	 of	 the	DMN	 report	 changes	 in	 superior	 pari-
etal	 and	 occipital	 regions	 (Agosta	 et	al.,	 2012;	 Lee	 et	al.,	 2016).	
These	findings	are	consistent	with	those	in	resting	and	visual	fMRI	
studies that report affected visual functioning accompanied by 
differences	 in	 the	 visual	 cortices	 (Alegret	 et	al.,	 2010;	 Lehmann	
et	al.,	 2013;	Wang	 et	al.,	 2015;	 Zhang	 et	al.,	 2010)	 and	 the	 idea	












This is in line with earlier findings of a change in “hub” status of 
these	brain	regions	in	AD	patients	(Buckner	et	al.,	2009;	de	Haan,	
Mott,	 et	al.,	 2012;	 de	Haan,	 van	 der	 Flier,	 et	al.,	 2012),	 and	 AD-	
related	changes	in	glucose	metabolism	(Ossenkoppele	et	al.,	2013)	
and	neuronal	activity	(Damoiseaux	et	al.,	2012;	Navas	et	al.,	2013).
The	 GAP	 cohort	 of	 healthy	 elderly	 with	 documented	 AD	 risk	
fills	the	gap	of	the	less	frequently	studied	group	of	elderly,	healthy	
adults	with	known	APOE-	ε4	genotype,	and	our	study	confirms	the	
persistence of these genotype- driven changes from young adults 
and	 elderly	 healthy	 stages	 to	 early	 and	 advanced	 stages	 of	 AD.	
The	efficiency	of	fast	ECM	(Wink	et	al.,	2012)	and	its	sensitivity	to	




whole- brain network analyses are an interesting and novel approach 
to multiple- network decompositions for neurological disorders 
that perturb the global brain network functionally and structurally 
(Agosta	 et	al.,	 2012;	 Seeley,	 Crawford,	 Zhou,	 Miller,	 &	 Greicius,	
2009;	Tijms	et	al.,	2014).
4.2 | Relation between occipital 
EC and nonimaging biomarkers
Older subjects showed lower eigenvector centrality values and 
a	 significant	 negative	 correlation	 with	 age	 across	 groups.	 (Tijms	
et	al.,	2014;	van	der	Flier,	Pijnenburg,	Fox,	&	Scheltens,	2011)	This	
decrease	is	in	line	with	recent	results	from	fMRI	studies	in	healthy	




corresponds to a negative correlation with amyloid load in the brain. 
This	 is	 consistent	with	 the	 finding	 that	 ECM	correlates	 negatively	
with	age,	because	brain	amyloid	load	correlates	positively	with	age	
(Oh,	Madison,	Baker,	Rabinovici,	&	Jagust,	2016).
Cluster	mean	EC	was	 also	 related	 to	 a	 decrease	 in	 normalized	
gray	matter	volume	(NGMV).	Atrophy	differences	in	this	cohort	re-





there was also a difference in scores between the groups: The 
APOE4+	group	had	higher	scores.	This	finding	is	somewhat	counter-
intuitive,	as	the	APOE4+	group	scored	higher	on	the	15OT.	The	plots	
per subgroup show that EC variability against test score is lower in 
e4	carriers.	This	indicates	differences	in	brain	network	organization	
between carriers and noncarriers that make the brain more vulner-
able	 to	AD-	related	 pathology	 (De	Meyer	 et	al.,	 2010;	 Evans	 et	al.,	
Effect of interest p value APOE 4−/4+
Linear fits in subgroups
APOE4− APOE4+








NGMV p	=	0.008* p	=	1.4	×	10−4* p	=	0.022* 
R2 = 0.028
p = 0.113 
R2 = 0.034
15OT	test	score p	=	0.001* p	=	1.6	×	10−5* p	=	0.000* 
R2 = 0.071










p	=	0.005* p	=	3.1	×	10−4* p	=	0.035* 
R2 = 0.024
p = 0.102 
R2 = 0.036
Note.	The	*	indicates	p	<0.05
TABLE  2 Correlations of biological 
markers	of	AD	risk	with	EC	means	
measured inside the cluster of significant 
between-	group	differences	(see	Figure	1b)
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F IGURE  2 Cluster	mean	EC	of	all	subjects	plotted	against	subject	age	(a),	CSF	amyloid	levels	(b),	NGMV	(c),	15-	object	test	score	(15OT)	
(d),	and	time	to	complete	the	trail-	making	test	(TMT)	part	A	(e)	and	part	B	(f)
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2014;	Mintun	et	al.,	2006;	Sperling	et	al.,	2011).	In	an	important	way,	
this does not lead to decreased cognitive decline or visuoperceptual 
performance.	Indeed,	previous	studies	have	reported	a	positive	ef-
fect	of	APOE-	ε4	on	cognition	in	young	and	middle-	aged	adults,	sug-
gesting	that	APOE-	ε4- related changes are beneficial in early life but 
detrimental	in	old	age	(Bunce,	Anstey,	Burns,	Christensen,	&	Easteal,	
2011;	 Rusted	 et	al.,	 2013).	 Improved	 attention	 in	 young	 APOE-	ε4 




Cluster	 mean	 EC	 variability	 is	 lower	 within	 the	 APOE4+	 high-	risk	
group. The mean EC is significantly higher in the low- risk group than 








4.3 | APOE- ε4- related centrality changes in the 
visual cortex
The regions where decreased centrality was detected in this study 
are	in	the	visual	cortex.	The	visual	cortex	and	regions	of	the	ventral	
visual processing stream involved in object recognition have been 
recognized	 as	 areas	 affected	 by	AD	 in	 studies	 of	 cortical	 atrophy	
and	using	object	recognition	fMRI	tasks	(Jacobs	et	al.,	2015).	Given	




Frackowiak,	 &	 Draganski,	 2013;	 Yao,	 Hu,	 Liang,	 Zhao,	 &	 Jackson,	
2012).
Our results are partly concordant with recent findings that 
APOE-	ε4 carriers show different brain activity during scene per-
ception	 (Shine,	 Hodgetts,	 Postans,	 Lawrence,	 &	 Graham,	 2015),	
and	 anatomically	 match	 previously	 reported	 cases	 of	 AD-	related	
visuoperceptual	deficits	(Chan	et	al.,	2015)	and	studies	of	posterior	
cortical	atrophy	(Crutch	et	al.,	2012;	Migliaccio	et	al.,	2012).
4.4 | Functional brain network centrality as a 
predictor of APOE genotype
The results for predicting the genetic risk group using the cluster 
mean	EC	yielded	AUC	and	accuracy	higher	than	chance,	but	below	
75%	(1	in	every	4	misclassified).	In	our	sample	of	healthy	elderly,	the	
changes in EC that can be measured between groups are too subtle 







on the brain network.
5  | LIMITATIONS AND FUTURE 
DIREC TIONS
The	limited	brain	coverage	of	the	slice	stack	used	for	the	fMRI	acqui-
sition does not fully employ the benefits of a whole- brain network 
analysis	like	ECM.	The	acquisition	parameters	were	chosen	to	limit	




whole- brain coverage to make optimal use of modern analysis meth-
ods.	Another	 limitation	 is	 that	 it	 is	unknown	who	will	develop	AD	
pathology; this will be clearer in follow- up studies of this sample that 
are ongoing.
6  | CONCLUSION
Using	 ECM	 of	 resting-	state	 fMRI	 data	 in	 healthy	 controls,	 we	
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APOE-	ε4	allele,	a	genetic	risk	factor	for	AD,	which	are	directly	linked	
to age and cognitive performance in healthy aging.
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